NutriBand (NTRB) EPS (Basic) (2016 - 2026)

NutriBand (NTRB) posted EPS (Basic) of -$0.1 for Q2 2026, down 22.86% sequentially from -$0.08 in Q1 2026, and up 49.74% YoY from -$0.07 in Q2 2025.

NutriBand (NTRB) EPS (Basic) (2016 - 2026) Analysis & Trends

NutriBand has reported EPS (Basic) for 11 years, with the latest figure at -$0.1 in Q2 2026.

Quarterly EPS (Basic) rose 49.74% year-over-year to -$0.1 in Q2 2026, while the trailing twelve-month figure through Apr 2026 was -$2.46 (down 68.48% YoY) and the FY2026 annual result came in at -$2.58, down 161.16% from the prior year.
EPS (Basic) declined to -$0.1 in Q2 2026 per NTRB's latest filing, from -$0.08 in the prior quarter.
Over five years, EPS (Basic) peaked at -$0.08 in Q2 2022 and troughed at -$2.12 in Q3 2025.
A 5-year average of -$0.31 and a median of -$0.18 in 2024 frame the typical range for EPS (Basic).
The sharpest annual moves came in 2025 and 2026: EPS (Basic) slumped 1276.84% in 2025, then jumped 84.01% in 2026.
Over 5 years, EPS (Basic) stood at -$0.14 in 2022, then plunged by 63.02% to -$0.22 in 2023, then soared by 45.37% to -$0.12 in 2024, then slumped by 161.67% to -$0.32 in 2025, then surged by 68.19% to -$0.1 in 2026.
According to Business Quant data, EPS (Basic) over the past three periods registered -$0.1, -$0.08, and -$0.32 for Q2 2026, Q1 2026, and Q4 2025 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	EPS (Basic) (Qtr)
1	Vertex Pharmaceuticals	139.65 Bn	131.79 Bn	2.84 Bn	4.34
2	Regeneron Pharmaceuticals	86.08 Bn	78.09 Bn	3.93 Bn	12.62
3	Argenx Se	65.16 Bn	59.98 Bn	1.37 Bn	7.59
4	Moderna	63.25 Bn	58.11 Bn	52.00 Mn	-1.96
5	BeOne Medicines	42.22 Bn	37.12 Bn	1.53 Bn	2.12
6	Alnylam Pharmaceuticals	31.26 Bn	27.95 Bn	992.69 Mn	1.23
7	BioNTech SE	28.96 Bn	10.57 Bn	668.28 Mn	-0.72
8	Insmed	27.40 Bn	26.24 Bn	358.27 Mn	-0.06
9	Royalty Pharma	27.19 Bn	26.35 Bn	-	0.18
10	NutriBand	48.20 Mn	44.19 Mn	196,801.00	-0.10

Download Data